Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial.

被引：13

作者：

Carvajal, Richard D.

Agulnik, Mark

Ryan, Christopher W.

Milhem, Mohammed M.

George, Suzanne

Jones, Robin Lewis

Chmielowski, Bartosz

Van Tine, Brian Andrew

Tawbi, Hussein Abdul-Hassan

Elias, Anthony D.

Read, William L.

Budd, G. Thomas

Hirman, Joe

Weiden, Paul

Bennett, Cathryn M.

Livingston, Philip O.

Hansen, David

Maki, Robert G.

Schwartz, Gary K.

Chugh, Rashmi

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[3] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA

[4] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Seattle Canc Care Alliance, Seattle, WA USA

[7] Univ Calif Los Angeles, Los Angeles, CA USA

[8] Washington Univ, St Louis, MO USA

[9] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[10] Univ Colorado, Ctr Canc, Aurora, CO USA

[11] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[12] Cleveland Clin, Cleveland, OH 44106 USA

[13] Pacific Northwest Stat Consulting Inc, Woodinville, WA USA

[14] Biopharma Consulting Serv, Seattle, WA USA

[15] MabVax Therapeut Inc, San Diego, CA USA

[16] Mt Sinai Sch Med, New York, NY USA

[17] Columbia Univ, Med Ctr, New York, NY USA

[18] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.10520

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10520

引用

页数：1